메뉴 건너뛰기




Volumn 7, Issue 4, 2012, Pages 332-338

Barriers to HIV treatment among people who use injection drugs: Implications for 'treatment as prevention'

Author keywords

AIDS; antiretroviral therapy; HIV; injection drug use; prevention

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; CD4 ANTIGEN;

EID: 84862535125     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328354bcc8     Document Type: Review
Times cited : (53)

References (79)
  • 1
    • 77949540488 scopus 로고    scopus 로고
    • HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage
    • Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010; 375:1014-1028.
    • (2010) Lancet , vol.375 , pp. 1014-1028
    • Mathers, B.M.1    Degenhardt, L.2    Ali, H.3
  • 2
    • 55749095381 scopus 로고    scopus 로고
    • Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review
    • Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372:1733-1745.
    • (2008) Lancet , vol.372 , pp. 1733-1745
    • Mathers, B.M.1    Degenhardt, L.2    Phillips, B.3
  • 3
    • 22544468063 scopus 로고    scopus 로고
    • Safer injection facility use and syringe sharing in injection drug users
    • DOI 10.1016/S0140-6736(05)66475-6, PII S0140673605664756
    • Kerr T, Tyndall M, Li K, et al. Safer injection facility use and syringe sharing in injection drug users [Internet]. Lancet 2005; 366:316-318. (Pubitemid 41019422)
    • (2005) Lancet , vol.366 , Issue.9482 , pp. 316-318
    • Kerr, T.1    Tyndall, M.2    Li, K.3    Montaner, J.4    Wood, E.5
  • 4
    • 77954512639 scopus 로고    scopus 로고
    • Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes [Internet]
    • Kerr T, Small W, Buchner C, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes [Internet]. Am J Public Health 2010; 100:1449-1453.
    • (2010) Am J Public Health , vol.100 , pp. 1449-1453
    • Kerr, T.1    Small, W.2    Buchner, C.3
  • 5
    • 0028211410 scopus 로고
    • HIV seroconversion in intravenous drug users in San Francisco, 1985-1990
    • Moss AR, Vranizan K, Gorter R, et al. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990 [Internet]. AIDS 1994; 8:223-231. (Pubitemid 24094119)
    • (1994) AIDS , vol.8 , Issue.2 , pp. 223-231
    • Moss, A.R.1    Vranizan, K.2    Gorter, R.3    Bacchetti, P.4    Watters, J.5    Osmond, D.6
  • 6
    • 78449293443 scopus 로고    scopus 로고
    • Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes [Internet]
    • Montaner JSG, Wood E, Kerr T, et al. Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes [Internet]. J Acquir Immune Defic Syndr 2010; 55:S5-S9.
    • (2010) J Acquir Immune Defic Syndr , vol.55
    • Montaner, J.S.G.1    Wood, E.2    Kerr, T.3
  • 7
    • 77956057163 scopus 로고    scopus 로고
    • Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco
    • Das M, Chu PL, Santos G-M, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 2010; 5:e11068.
    • (2010) PLoS ONE , vol.5
    • Das, M.1    Chu, P.L.2    Santos, G.-M.3
  • 8
    • 67650035326 scopus 로고    scopus 로고
    • Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort study
    • Wood E, Kerr T, Marshall BDL, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. Br Med J 2009; 338:b1649-b11649.
    • (2009) Br Med J , vol.338
    • Wood, E.1    Kerr, T.2    Marshall, B.D.L.3
  • 9
    • 80051633217 scopus 로고    scopus 로고
    • Prevention of HIV-1 infection with early antiretroviral therapy
    • Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
    • (2011) N Engl J Med , vol.365 , pp. 493-505
    • Cohen, M.S.1    Chen, Y.Q.2    McCauley, M.3
  • 10
    • 75349103546 scopus 로고    scopus 로고
    • The Antiretroviral Therapy Cohort Collaboration. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries
    • The Antiretroviral Therapy Cohort Collaboration. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 2009; 38:1624-1633.
    • (2009) Int J Epidemiol , vol.38 , pp. 1624-1633
  • 11
    • 34248589717 scopus 로고    scopus 로고
    • Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies [Internet]
    • Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies [Internet]. AIDS 2007; 21:1185-1197.
    • (2007) AIDS , vol.21 , pp. 1185-1197
  • 14
    • 0142186280 scopus 로고    scopus 로고
    • Determinants of survival following HIV-1 seroconversion after the introduction of HAART
    • DOI 10.1016/S0140-6736(03)14570-9
    • Porter K, Babiker A, Bhaskaran K, et al., CASCADE Collaboration. Determinants of survival following HIV-1 seroconversion after the introduction of HAART [Internet]. Lancet 2003; 362:1267-1274. (Pubitemid 37324254)
    • (2003) Lancet , vol.362 , Issue.9392 , pp. 1267-1274
    • Porter, K.1
  • 15
    • 79960713621 scopus 로고    scopus 로고
    • Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: A population-based nationwide cohort study
    • Obel N, Omland LH, Kronborg G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS ONE 2011; 6:e22698
    • (2011) PLoS ONE , vol.6
    • Obel, N.1    Omland, L.H.2    Kronborg, G.3
  • 16
    • 82855160980 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention (CDC). Vital signs: HIV prevention through care and treatment: United States
    • Centers for Disease Control and Prevention (CDC). Vital signs: HIV prevention through care and treatment: United States. Morb Mortal Wkly Rep 2011; 60:1618-1623.
    • (2011) Morb Mortal Wkly Rep , vol.60 , pp. 1618-1623
  • 18
    • 33747365020 scopus 로고    scopus 로고
    • Drugs of abuse, immune modulation, and AIDS
    • DOI 10.1007/s11481-006-9023-5
    • Cabral GA. Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharm 2006; 1:280-295. (Pubitemid 44244133)
    • (2006) Journal of Neuroimmune Pharmacology , vol.1 , Issue.3 , pp. 280-295
    • Cabral, G.A.1
  • 19
    • 64249165706 scopus 로고    scopus 로고
    • Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users [Internet]
    • Baum MK, Rafie C, Lai S, et al. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users [Internet]. J Acquir Immune Defic Syndr 2009; 50:93-99.
    • (2009) J Acquir Immune Defic Syndr , vol.50 , pp. 93-99
    • Baum, M.K.1    Rafie, C.2    Lai, S.3
  • 20
    • 78751608934 scopus 로고    scopus 로고
    • Psychiatric risk factors for HIV disease progression: The role of inconsistent patterns of antiretroviral therapy utilization [Internet]
    • Carrico AW, Riley ED, Johnson MO, et al. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization [Internet]. J Acquir Immune Defic Syndr 2011; 56:146-150
    • (2011) J Acquir Immune Defic Syndr , vol.56 , pp. 146-150
    • Carrico, A.W.1    Riley, E.D.2    Johnson, M.O.3
  • 21
    • 79954713151 scopus 로고    scopus 로고
    • Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users
    • Fairbairn N, Kerr T, Milloy M-J, et al. Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addict Behav 2011; 36:762-763.
    • (2011) Addict Behav , vol.36 , pp. 762-763
    • Fairbairn, N.1    Kerr, T.2    Milloy, M.-J.3
  • 22
    • 79955550510 scopus 로고    scopus 로고
    • Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts
    • McGowan CC, Weinstein DD, Samenow CP, et al. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS ONE 2011; 6:e18462.
    • (2011) PLoS ONE , vol.6
    • McGowan, C.C.1    Weinstein, D.D.2    Samenow, C.P.3
  • 23
    • 79957991658 scopus 로고    scopus 로고
    • The relationship between injection and noninjection drug use and HIV disease progression
    • Qian H-Z, Stinnette S, Rebeiro P, et al. The relationship between injection and noninjection drug use and HIV disease progression. J Subst Abuse Treat 2011; 41:14-20.
    • (2011) J Subst Abuse Treat , vol.41 , pp. 14-20
    • Qian, H.-Z.1    Stinnette, S.2    Rebeiro, P.3
  • 24
    • 0347504668 scopus 로고    scopus 로고
    • Higher baseline levels of plasma human immunodeficiency virus type 1 RNA Are associated with increased mortality after initiation of triple-drug antiretroviral therapy
    • DOI 10.1086/379201
    • Wood E, Hogg RS, Yip B, et al. Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy [Internet]. J Infect Dis 2003; 188:1421-1425. (Pubitemid 37523926)
    • (2003) Journal of Infectious Diseases , vol.188 , Issue.10 , pp. 1421-1425
    • Wood, E.1    Hogg, R.S.2    Yip, B.3    Quercia, R.4    Harrigan, P.R.5    O'Shaughnessy, M.V.6    Montaner, J.S.G.7
  • 25
    • 0242364652 scopus 로고    scopus 로고
    • Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy
    • DOI 10.1086/378703
    • Wood E, Montaner JSG, Tyndall MW, et al. Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy [Internet]. J Infect Dis 2003; 188:1164-1170. (Pubitemid 37338981)
    • (2003) Journal of Infectious Diseases , vol.188 , Issue.8 , pp. 1164-1170
    • Wood, E.1    Montaner, J.S.G.2    Tyndall, M.W.3    Schechter, M.T.4    O'Shaughnessy, M.V.5    Hogg, R.S.6
  • 26
    • 79956323731 scopus 로고    scopus 로고
    • Association of ongoing drug and alcohol use with nonadherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362
    • Cohn SE, Jiang H, McCutchan JA, et al. Association of ongoing drug and alcohol use with nonadherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care 2011; 23:775-785.
    • (2011) AIDS Care , vol.23 , pp. 775-785
    • Cohn, S.E.1    Jiang, H.2    McCutchan, J.A.3
  • 27
    • 48749086250 scopus 로고    scopus 로고
    • Highly active antiretroviral therapy and survival in HIV-infected injection drug users [Internet]
    • Wood E, Hogg RS, Lima VD, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users [Internet]. J Am Med Assoc 2008; 300:550-554.
    • (2008) J Am Med Assoc , vol.300 , pp. 550-554
    • Wood, E.1    Hogg, R.S.2    Lima, V.D.3
  • 28
    • 84861855800 scopus 로고    scopus 로고
    • Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users
    • doi: 10.1016/j.drugalcdep.2011. 12.019
    • Kerr T, Marshall BDL, Milloy M-J, et al. Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users. Drug Alcohol Depend 2012. doi: 10.1016/j.drugalcdep.2011. 12.019.
    • (2012) Drug Alcohol Depend
    • Kerr, T.1    Marshall, B.D.L.2    Milloy, M.-J.3
  • 29
    • 77955714260 scopus 로고    scopus 로고
    • Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
    • Altice FL, Kamarulzaman A, Soriano VV, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010; 376:367-387.
    • (2010) Lancet , vol.376 , pp. 367-387
    • Altice, F.L.1    Kamarulzaman, A.2    Soriano, V.V.3
  • 30
    • 79952487759 scopus 로고    scopus 로고
    • Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence
    • Meade CS, Conn NA, Skalski LM, Safren SA. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. J Behav Med 2010; 34:128-138.
    • (2010) J Behav Med , vol.34 , pp. 128-138
    • Meade, C.S.1    Conn, N.A.2    Skalski, L.M.3    Safren, S.A.4
  • 31
    • 82355180004 scopus 로고    scopus 로고
    • Depressive symptoms and food insufficiency among HIV-infected crack users in Atlanta and Miami
    • Vogenthaler NS, Hadley C, Rodriguez AE, et al. Depressive symptoms and food insufficiency among HIV-infected crack users in Atlanta and Miami. AIDS Behav 2010; 15:1520-1526.
    • (2010) AIDS Behav , vol.15 , pp. 1520-1526
    • Vogenthaler, N.S.1    Hadley, C.2    Rodriguez, A.E.3
  • 32
    • 79956302164 scopus 로고    scopus 로고
    • High prevalence of childhood emotional, physical and sexual trauma among a Canadian cohort of HIV-seropositive illicit drug users
    • Walton G, Co SJ, Milloy M-J, et al. High prevalence of childhood emotional, physical and sexual trauma among a Canadian cohort of HIV-seropositive illicit drug users. AIDS Care 2011; 23:714-721.
    • (2011) AIDS Care , vol.23 , pp. 714-721
    • Walton, G.1    Co, S.J.2    Milloy, M.-J.3
  • 33
  • 34
    • 80055066403 scopus 로고    scopus 로고
    • The unrealized potential of addiction science in curbing the HIVepidemic [Internet]
    • D Volkow N, D Baler R, L Normand J. The unrealized potential of addiction science in curbing the HIVepidemic [Internet]. Curr HIVRes 2011; 9:393-395.
    • (2011) Curr HIVRes , vol.9 , pp. 393-395
    • Volkow N, D.1    Baler R, D.2    Normand J, L.3
  • 35
    • 19544368020 scopus 로고    scopus 로고
    • An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research
    • DOI 10.1016/j.jsat.2005.02.007, PII S0740547205000498
    • Amato L, Davoli M, Aperucci C, et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and researC.H. J Subst Abuse Treat 2005; 28:321-329. (Pubitemid 40733141)
    • (2005) Journal of Substance Abuse Treatment , vol.28 , Issue.4 , pp. 321-329
    • Amato, L.1    Davoli, M.2    Perucci, C.A.3    Ferri, M.4    Faggiano, F.5    Mattick, R.P.6
  • 36
    • 54049149928 scopus 로고    scopus 로고
    • The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF2000 cohort study
    • Roux P, Carrieri MP, Villes V, et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction 2008; 103:1828-1836.
    • (2008) Addiction , vol.103 , pp. 1828-1836
    • Roux, P.1    Carrieri, M.P.2    Villes, V.3
  • 37
    • 77950677605 scopus 로고    scopus 로고
    • Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users
    • Uhlmann S, Milloy M-J, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction 2010; 105:907-913.
    • (2010) Addiction , vol.105 , pp. 907-913
    • Uhlmann, S.1    Milloy, M.-J.2    Kerr, T.3
  • 38
    • 79951775696 scopus 로고    scopus 로고
    • HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study [Internet]
    • Altice FL, Bruce RD, Lucas GM, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study [Internet]. J Acquir Immune Defic Syndr 2011; 56 (SUPPL. 1):S22-S32.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Altice, F.L.1    Bruce, R.D.2    Lucas, G.M.3
  • 39
    • 79951792799 scopus 로고    scopus 로고
    • Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIVcare [Internet]
    • Chaudhry AA, Botsko M, Weiss L, et al. Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIVcare [Internet]. J Acquir ImmuneDefic Syndr2011;56(SUPPL. 1):S14-S21.
    • (2011) J Acquir ImmuneDefic Syndr , vol.56 , Issue.SUPPL. 1
    • Chaudhry, A.A.1    Botsko, M.2    Weiss, L.3
  • 40
    • 79951782715 scopus 로고    scopus 로고
    • Patient perspectives on buprenorphine/ naloxone treatment in the context of HIV care [Internet]
    • Egan JE, Netherland J, Gass J, et al. Patient perspectives on buprenorphine/ naloxone treatment in the context of HIV care [Internet]. J Acquir Immune Defic Syndr 2011; 56 (SUPPL. 1):S46-S53.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Egan, J.E.1    Netherland, J.2    Gass, J.3
  • 41
    • 79951777614 scopus 로고    scopus 로고
    • Improved quality of life for opioiddependent patients receiving buprenorphine treatment in HIV clinics [Internet]
    • Korthuis PT, Tozzi MJ, Nandi V, et al. Improved quality of life for opioiddependent patients receiving buprenorphine treatment in HIV clinics [Internet]. J Acquir Immune Defic Syndr 2011; 56 (SUPPL. 1):S39-S45.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Korthuis, P.T.1    Tozzi, M.J.2    Nandi, V.3
  • 42
    • 79951802471 scopus 로고    scopus 로고
    • Improving adherence to HIV quality of care indicators in persons with opioid dependence: The role of buprenorphine [Internet]
    • Korthuis PT, Fiellin DA, Fu R, et al. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine [Internet]. J Acquir Immune Defic Syndr 2011; 56 (SUPPL. 1):S83-S90.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Korthuis, P.T.1    Fiellin, D.A.2    Fu, R.3
  • 43
    • 79951792603 scopus 로고    scopus 로고
    • BHIVES Collaborative.Hepatic safety and lack of antiretroviral interactions with buprenorphine/ naloxone in HIV-infected opioid-dependent patients [Internet]
    • Vergara-Rodriguez P, Tozzi MJ, Botsko M, et al., BHIVES Collaborative. Hepatic safety and lack of antiretroviral interactions with buprenorphine/ naloxone in HIV-infected opioid-dependent patients [Internet] J Acquir Immune Defic Syndr 2011; 56(SUPPL. 1):S62-S67.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Vergara-Rodriguez, P.1    Tozzi, M.J.2    Botsko, M.3
  • 44
    • 79951779992 scopus 로고    scopus 로고
    • Integration of buprenorphine/naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative [Internet]
    • Weiss L, Netherland J, Egan JE, et al. Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative [Internet]. J Acquir Immune Defic Syndr 2011; 56 (SUPPL. 1):S68-S75.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Weiss, L.1    Netherland, J.2    Egan, J.E.3
  • 45
    • 33646724904 scopus 로고    scopus 로고
    • Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups [Internet]
    • Lucas GM, Mullen BA, Weidle PJ, et al. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups [Internet]. Clin Infect Dis 2006; 42:1628-1635.
    • (2006) Clin Infect Dis , vol.42 , pp. 1628-1635
    • Lucas, G.M.1    Mullen, B.A.2    Weidle, P.J.3
  • 46
    • 72049114441 scopus 로고    scopus 로고
    • Directly observed antiretroviral therapy: A systematic review and meta-analysis of randomised clinical trials
    • Ford N, Nachega JB, Engel ME, Mills EJ. Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet 2009; 374:2064-2071.
    • (2009) Lancet , vol.374 , pp. 2064-2071
    • Ford, N.1    Nachega, J.B.2    Engel, M.E.3    Mills, E.J.4
  • 47
    • 34548499506 scopus 로고    scopus 로고
    • Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial
    • DOI 10.1086/521166
    • Altice FL, Maru DSR, Bruce RD, et al. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis 2007; 45:770-778. (Pubitemid 47378892)
    • (2007) Clinical Infectious Diseases , vol.45 , Issue.6 , pp. 770-778
    • Altice, F.L.1    Maru, D.S.-R.2    Bruce, R.D.3    Springer, S.A.4    Friedland, G.H.5
  • 48
    • 78651494300 scopus 로고    scopus 로고
    • Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial
    • Berg KM, Litwin A, Li X, et al. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug Alcohol Depend 2011; 113:192-199.
    • (2011) Drug Alcohol Depend , vol.113 , pp. 192-199
    • Berg, K.M.1    Litwin, A.2    Li, X.3
  • 49
    • 79957619708 scopus 로고    scopus 로고
    • Targeting candidates for directly administered highly active antiretroviral therapy: Benefits observed in HIVinfected injecting drug users in residential drug-rehabilitation facilities
    • Babudieri S, Dorrucci M, Boschini A, et al. Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIVinfected injecting drug users in residential drug-rehabilitation facilities. AIDS Patient Care STDS 2011; 25:359-364.
    • (2011) AIDS Patient Care STDS , vol.25 , pp. 359-364
    • Babudieri, S.1    Dorrucci, M.2    Boschini, A.3
  • 50
    • 66749160901 scopus 로고    scopus 로고
    • Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment
    • Bell J, Trinh L, Butler B, et al. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction 2009; 104:1193-1200.
    • (2009) Addiction , vol.104 , pp. 1193-1200
    • Bell, J.1    Trinh, L.2    Butler, B.3
  • 51
    • 79951782548 scopus 로고    scopus 로고
    • Drug treatment outcomes among HIVinfected opioid-dependent patients receiving buprenorphine/naloxone [Internet]
    • Fiellin DA, Weiss L, Botsko M, et al. Drug treatment outcomes among HIVinfected opioid-dependent patients receiving buprenorphine/naloxone [Internet]. J Acquir Immune Defic Syndr 2011; 56 (SUPPL. 1):S33-S38.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Fiellin, D.A.1    Weiss, L.2    Botsko, M.3
  • 52
    • 80054088667 scopus 로고    scopus 로고
    • Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention [Internet]
    • Berg KM, Litwin AH, Li X, et al. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention [Internet]. Clin Infect Dis 2011; 53:936-943.
    • (2011) Clin Infect Dis , vol.53 , pp. 936-943
    • Berg, K.M.1    Litwin, A.H.2    Li, X.3
  • 53
    • 84856291087 scopus 로고    scopus 로고
    • Heroin maintenance for chronic heroindependent individuals [Internet]
    • Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroindependent individuals [Internet]. Cochrane Database Syst Rev 2011; 12:CD003410.
    • (2011) Cochrane Database Syst Rev , vol.12
    • Ferri, M.1    Davoli, M.2    Perucci, C.A.3
  • 54
    • 79951791597 scopus 로고    scopus 로고
    • The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone [Internet]
    • Sullivan LE, Botsko M, Cunningham CO, et al. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone [Internet]. J Acquir Immune Defic Syndr 2011; 56 (SUPPL. 1):S54-S61.
    • (2011) J Acquir Immune Defic Syndr , vol.56 , Issue.SUPPL. 1
    • Sullivan, L.E.1    Botsko, M.2    Cunningham, C.O.3
  • 56
    • 84855168566 scopus 로고    scopus 로고
    • Informal care and reciprocity of support are associated with HAART adherence among men in Baltimore, MD, USA
    • Knowlton AR, Yang C, Bohnert A, et al. Informal care and reciprocity of support are associated with HAART adherence among men in Baltimore, MD, USA. AIDS Behav 2010; 15:1429-1436.
    • (2010) AIDS Behav , vol.15 , pp. 1429-1436
    • Knowlton, A.R.1    Yang, C.2    Bohnert, A.3
  • 57
    • 79960005337 scopus 로고    scopus 로고
    • Substance use and the quality of patient-provider communication in HIV clinics
    • Korthuis PT, Saha S, Chander G, et al. Substance use and the quality of patient-provider communication in HIV clinics. AIDS Behav 2010; 15:832-841.
    • (2010) AIDS Behav , vol.15 , pp. 832-841
    • Korthuis, P.T.1    Saha, S.2    Chander, G.3
  • 58
    • 79956361350 scopus 로고    scopus 로고
    • Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam [Internet]
    • Lambers FAE, Stolte IG, van den Berg CHSB, et al. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam [Internet]. Int J Drug Policy 2011; 22:210-218.
    • (2011) Int J Drug Policy , vol.22 , pp. 210-218
    • Lambers, F.A.E.1    Stolte, I.G.2    Van Den Berg, C.H.S.B.3
  • 59
    • 79952524583 scopus 로고    scopus 로고
    • Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence [Internet]
    • Lehavot K, Huh D, Walters KL, et al. Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence [Internet]. AIDS Patient Care STDS 2011; 25:181-189.
    • (2011) AIDS Patient Care STDS , vol.25 , pp. 181-189
    • Lehavot, K.1    Huh, D.2    Walters, K.L.3
  • 60
    • 1642365729 scopus 로고    scopus 로고
    • Social support and patient adherence to medical treatment: A meta-analysis [Internet]
    • DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis [Internet]. Health Psychol 2004; 23:207-218.
    • (2004) Health Psychol , vol.23 , pp. 207-218
    • Dimatteo, M.R.1
  • 61
    • 33646079379 scopus 로고    scopus 로고
    • NIMH Healthy Living Project Team. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model
    • Johnson MO, Chesney MA, Goldstein RB, et al., NIMH Healthy Living Project Team. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: a mediation model. AIDS Patient Care STDS 2006; 20:258-268.
    • (2006) AIDS Patient Care STDS , vol.20 , pp. 258-268
    • Johnson, M.O.1    Chesney, M.A.2    Goldstein, R.B.3
  • 62
    • 83455206097 scopus 로고    scopus 로고
    • Preliminary evidence of significant gaps in continuity of HIV care among excarcerated populations in Puerto Rico
    • Clatts MC, Rodriguez-Diaz CE, Garcia H, et al. Preliminary evidence of significant gaps in continuity of HIV care among excarcerated populations in Puerto Rico. J Int Assoc Phys AIDS Care 2011; 10:339-341.
    • (2011) J Int Assoc Phys AIDS Care , vol.10 , pp. 339-341
    • Clatts, M.C.1    Rodriguez-Diaz, C.E.2    Garcia, H.3
  • 63
    • 84859741786 scopus 로고    scopus 로고
    • Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy
    • doi: 10.1097/ QAI.0b013e3182433288
    • Milloy M.-J., Kerr T, Buxton J, et al. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2011. doi: 10.1097/ QAI.0b013e3182433288.
    • (2011) J Acquir Immune Defic Syndr
    • Milloy, M.-J.1    Kerr, T.2    Buxton, J.3
  • 64
    • 79954612445 scopus 로고    scopus 로고
    • Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users
    • Milloy M-J, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis 2011; 203:1215-1221.
    • (2011) J Infect Dis , vol.203 , pp. 1215-1221
    • Milloy, M.-J.1    Kerr, T.2    Buxton, J.3
  • 65
    • 80052484608 scopus 로고    scopus 로고
    • Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy
    • Westergaard RP, Kirk GD, Richesson DR, et al. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis 2011; 53:725-731.
    • (2011) Clin Infect Dis , vol.53 , pp. 725-731
    • Westergaard, R.P.1    Kirk, G.D.2    Richesson, D.R.3
  • 66
    • 84885434378 scopus 로고    scopus 로고
    • Disease progression and characteristics of HIV-infected women with and without a history of criminal justice involvement
    • doi: 10.1007/s10461-011-0057-1
    • Youmans E, Burch J, Moran R, et al. Disease progression and characteristics of HIV-infected women with and without a history of criminal justice involvement. AIDS Behav 2011. doi: 10.1007/s10461-011-0057-1.
    • AIDS Behav 2011
    • Youmans, E.1    Burch, J.2    Moran, R.3
  • 67
    • 79954568865 scopus 로고    scopus 로고
    • The intertwined epidemics of HIV infection, incarceration, and substance abuse: A call to action
    • Flanigan TP, Beckwith CG. The intertwined epidemics of HIV infection, incarceration, and substance abuse: a call to action. J Infect Dis 2011; 203:1201-1203.
    • (2011) J Infect Dis , vol.203 , pp. 1201-1203
    • Flanigan, T.P.1    Beckwith, C.G.2
  • 69
    • 61449162171 scopus 로고    scopus 로고
    • Accessing antiretroviral therapy following release from prison [Internet]
    • Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison [Internet]. J Am Med Assoc 2009; 301:848-857.
    • (2009) J Am Med Assoc , vol.301 , pp. 848-857
    • Baillargeon, J.1    Giordano, T.P.2    Rich, J.D.3
  • 70
    • 79957601311 scopus 로고    scopus 로고
    • Attitudes toward opioid substitution therapy and preincarceration HIV transmission behaviors among HIVinfected prisoners in Malaysia: Implications for secondary prevention
    • Bachireddy C, Bazazi AR, Kavasery R, et al. Attitudes toward opioid substitution therapy and preincarceration HIV transmission behaviors among HIVinfected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend 2011; 116:151-157.
    • (2011) Drug Alcohol Depend , vol.116 , pp. 151-157
    • Bachireddy, C.1    Bazazi, A.R.2    Kavasery, R.3
  • 71
    • 79956349686 scopus 로고    scopus 로고
    • Incarceration, sex with an STI-or HIV-infected partner, and infection with an STI or HIV in Bushwick, Brooklyn, NY: A social network perspective [Internet]
    • Khan MR, Epperson MW, Mateu-Gelabert P, et al. Incarceration, sex with an STI-or HIV-infected partner, and infection with an STI or HIV in Bushwick, Brooklyn, NY: a social network perspective [Internet]. Am J Public Health 2011; 101:1110-1117.
    • (2011) Am J Public Health , vol.101 , pp. 1110-1117
    • Khan, M.R.1    Epperson, M.W.2    Mateu-Gelabert, P.3
  • 74
    • 80054709151 scopus 로고    scopus 로고
    • Compulsory drug detention center experiences among a community-based sample of injection drug users in Bangkok, Thailand
    • Csete J, Kaplan K, Hayashi K, et al. Compulsory drug detention center experiences among a community-based sample of injection drug users in Bangkok, Thailand. BMC Int Health Human Rights 2011; 11:12.
    • (2011) BMC Int Health Human Rights , vol.11 , pp. 12
    • Csete, J.1    Kaplan, K.2    Hayashi, K.3
  • 75
    • 79960155517 scopus 로고    scopus 로고
    • Predictors of incident and recurrent participation in the sale or delivery of drugs for profit amongst young methamphetamine users in Chiang Mai Province, Thailand, 2005-2006
    • Latimore AD, Rudolph A, German D, et al. Predictors of incident and recurrent participation in the sale or delivery of drugs for profit amongst young methamphetamine users in Chiang Mai Province, Thailand, 2005-2006. Int J Drug Policy 2011; 22:259-266.
    • (2011) Int J Drug Policy , vol.22 , pp. 259-266
    • Latimore, A.D.1    Rudolph, A.2    German, D.3
  • 76
    • 80052188398 scopus 로고    scopus 로고
    • Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women
    • Riley ED, Moore K, Sorensen JL, et al. Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women. Am J Epidemiol 2011; 174:515-522.
    • (2011) Am J Epidemiol , vol.174 , pp. 515-522
    • Riley, E.D.1    Moore, K.2    Sorensen, J.L.3
  • 77
    • 79953280654 scopus 로고    scopus 로고
    • Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare
    • Tapp C, Milloy M-J, Kerr T, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis 2011; 11:86.
    • (2011) BMC Infect Dis , vol.11 , pp. 86
    • Tapp, C.1    Milloy, M.-J.2    Kerr, T.3
  • 78
    • 77956058280 scopus 로고    scopus 로고
    • Time to act: A call for comprehensive responses to HIV in people who use drugs
    • Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, et al. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet 2010; 376:551-563.
    • (2010) Lancet , vol.376 , pp. 551-563
    • Beyrer, C.1    Malinowska-Sempruch, K.2    Kamarulzaman, A.3
  • 79
    • 77955775481 scopus 로고    scopus 로고
    • Vienna Declaration: A call for evidence-based drug policies
    • Wood E, Werb D, Kazatchkine M, et al. Vienna Declaration: a call for evidence-based drug policies. Lancet 2010; 376:310-312.
    • (2010) Lancet , vol.376 , pp. 310-312
    • Wood, E.1    Werb, D.2    Kazatchkine, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.